EQS-Adhoc: Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Strategic Company Decision Marinomed Biotech AG evaluates strategic options for Carragelose portfolio 18-Dec-2023 / 08:30 CET/CEST Disclosure of an inside information acc. to…